VYNE Therapeutics Inc. (VYNE)
NASDAQ: VYNE · Real-Time Price · USD
1.420
-0.200 (-12.35%)
At close: Jun 27, 2025, 4:00 PM
1.440
+0.020 (1.42%)
After-hours: Jun 27, 2025, 7:58 PM EDT
VYNE Therapeutics Market Cap
VYNE Therapeutics has a market cap or net worth of $23.66 million as of June 27, 2025. Its market cap has decreased by -34.06% in one year.
Market Cap
23.66M
Enterprise Value
-26.54M
1-Year Change
-34.06%
Ranking
Category
Stock Price
$1.42
Market Cap Chart
Since March 10, 2020, VYNE Therapeutics's market cap has decreased from $229.74M to $23.66M, a decrease of -89.70%. That is a compound annual growth rate of -35.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 15.67M | -68.29% |
| Dec 31, 2024 | 49.42M | 51.96% |
| Dec 29, 2023 | 32.52M | 273.57% |
| Dec 30, 2022 | 8.71M | -84.05% |
| Dec 31, 2021 | 54.59M | -79.42% |
| Dec 31, 2020 | 265.25M | 15.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |